When Reassurance Turns Into a Risk
A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals that stall, tests that never get ordered, and follow-up that simply vanishes into the machinery of care.
This is not a stock story, and it would be tasteless to pretend otherwise. It is a patient-safety story with legal consequences sitting in the background. Hodes Milman, an Irvine-based law firm representing patients and families in malpractice and injury cases, is putting a bright light on a grim fact: diagnostic harm often comes from a chain of small misses, not one cinematic blunder.
The Gaps Are Often Tedious, Not Dramatic
That is precisely why this deserves attention. A suspicious image can be under-called. A recommended MRI may not be ordered. A patient reporting a lump may be told to wait. Someone may assume another clinician owns the next step. None of that sounds exotic. It sounds like ordinary administrative slippage, which is what makes it so maddening. Ordinary slippage can carry extraordinary stakes when cancer is involved.
Hodes Milman says the project will examine misinterpreted imaging, delayed referrals, and incomplete follow-up while helping patients understand when to request records, ask about additional testing, or seek a second opinion. The firm’s central point is blunt and fair: a reassuring result that does not square with persistent symptoms deserves a clearer conversation, not a shrug.
- Request imaging reports rather than relying only on a verbal summary.
- Ask who is responsible for ordering and tracking the next test.
- Clarify what an imaging result means and whether follow-up is recommended.
- Raise persistent symptoms again, even after a reassuring result.
Access Problems Compound the Clinical Ones
The initiative also plans to examine racial disparities, barriers for rural patients, and challenges facing women under 50. Those are not decorative footnotes. Access to imaging, specialist appointments, transportation, insurance navigation, and timely follow-up can vary sharply depending on where a patient lives and how easily she can move through a fragmented system. A recommendation on paper is not the same thing as care received.
Women under 50 can face a particularly frustrating layer of uncertainty because symptoms, family history, screening patterns, and imaging decisions do not always follow a neat, one-size-fits-all path. The source material does not offer statewide case counts, research methodology, or a timetable for the project’s findings. That matters. This announcement is an advocacy and education initiative from a plaintiff-side law firm, not an independent epidemiological report. Still, the concerns it raises are concrete enough that ducking behind the absence of a fresh spreadsheet would be foolish.
Patients Should Not Carry the Whole Burden
There is an uncomfortable tension here. Encouraging people to obtain reports and ask sharper questions is sensible. Yet patients should not have to serve as their own scheduling department, records clerk, and quality-control officer while dealing with fear and uncertainty. Hodes Milman says exactly that: people should not have to become their own safety net. No argument from me.
Healthcare organizations ought to hear the operational warning in this project, even if they dislike the legal framing. Closed-loop communication, documented responsibility for follow-up, accessible records, and escalation pathways for unresolved symptoms are not glamorous improvements. They are the unsexy plumbing of safer care. Ignore the plumbing long enough and eventually something leaks where it should not.
A Useful Spotlight, With Questions Still Open
The project does not claim that every delayed diagnosis is preventable, nor should anyone imply that a normal scan automatically reflects negligence. Medicine is complicated; imaging has limits; cancer biology can be cruel. But complexity is not an excuse for vague handoffs or unanswered questions. California’s patients, particularly those facing geographic or racial barriers, deserve timely explanations and clear ownership of next steps.
For now, the value of this initiative is in forcing that conversation into daylight. The eventual measure of its usefulness will be whether it helps people obtain clearer answers sooner and pushes care systems to close the gaps that too often get dismissed as somebody else’s problem.